Neurotropin

· Nippon Zoki Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Neurotropin, covering 2016-06-21 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients [Phase 3]

See pricing